Psychology & Intimacy ETH Zurich Researchers Develop Experimental Compound That Targets GRK2 Enzyme to Slow Alzheimer’s Progression and Protect Mitochondria September 14, 2026 Rebecca Shoemaker A team of molecular pharmacologists at ETH Zurich has developed an experimental chemical substance, designated as Compound 10, that offers a novel therapeutic approach to slowing the neurodegenerative progression of…
